| 661988 |
FRONTIERS IN ONCOLOGY |
Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level |
2021-03-05 |
10.3389/fonc.2021.606820 |
Zimmermann Michael T., Mathison Angela J., Stodola Tim, Evans Douglas B., Abrudan Jenica L., Demos Wendy, Tschannen Michael, Aldakkak Mohammed, Geurts Jennifer, Lomberk Gwen, Tsai Susan, Urrutia Raul |
| 661987 |
FRONTIERS IN ONCOLOGY |
Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses |
2021-03-05 |
10.3389/fonc.2021.581030 |
Chen Donglai, Wang Yifei, Zhang Xi, Ding Qifeng, Wang Xiaofan, Xue Yuhang, Wang Wei, Mao Yiming, Chen Chang, Chen Yongbing |
| 661986 |
FRONTIERS IN ONCOLOGY |
The Prognostic Value of Radiomics Features Extracted From Computed Tomography in Patients With Localized Clear Cell Renal Cell Carcinoma After Nephrectomy |
2021-03-05 |
10.3389/fonc.2021.591502 |
Tang Xin, Pang Tong, Yan Wei-feng, Qian Wen-lei, Gong You-ling, Yang Zhi-gang |
| 661985 |
FRONTIERS IN ONCOLOGY |
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China |
2021-03-05 |
10.3389/fonc.2021.607531 |
Chen Xiaoling, Nie Jun, Dai Ling, Hu Weiheng, Zhang Jie, Han Jindi, Ma Xiangjuan, Tian Guangming, Han Sen, Wu Di, Wang Yang, Long Jieran, Zhang Ziran, Fang Jian |
| 661984 |
FRONTIERS IN ONCOLOGY |
Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging |
2021-03-05 |
10.3389/fonc.2021.593636 |
Minami Yasunori, Kudo Masatoshi |
| 661983 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of S100P Expression in Patients With Digestive System Cancers: A Meta-Analysis |
2021-03-05 |
10.3389/fonc.2021.593728 |
Liu Bi-Xia, Tang Chao-Tao, Dai Xi-Jian, Zeng Ling, Cheng Fei, Chen Youxiang, Zeng Chunyan |
| 661982 |
FRONTIERS IN ONCOLOGY |
Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas |
2021-03-05 |
10.3389/fonc.2021.596290 |
dos Santos Lucas V., Abrahão Carina M., William William N. |
| 661981 |
FRONTIERS IN ONCOLOGY |
Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis |
2021-03-05 |
10.3389/fonc.2021.601185 |
Qiu Lingxiao, Song Pan, Chen Pingmei, Wang Huaqi, Li Fangfang, Shu Mengxuan, Gong Gen-cheng, Song Xiangjin, Huang Chun, Jia Hongxia, Li Nana, Zhang Guojun |
| 661980 |
FRONTIERS IN ONCOLOGY |
Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study |
2021-03-05 |
10.3389/fonc.2021.603031 |
Zhang Shuairan, Liu Yang, Jiao Zihan, Li Zenan, Wang Jin, Li Ce, Qu Xiujuan, Xu Ling |
| 661979 |
FRONTIERS IN ONCOLOGY |
Prognostic Relevance of Expression of EMP1, CASP1, and NLRP3 Genes in Pediatric B-Lineage Acute Lymphoblastic Leukemia |
2021-03-05 |
10.3389/fonc.2021.606370 |
Singh Jay, Kumari Sarita, Arora Mohit, Verma Deepak, Palanichamy Jayanth Kumar, Kumar Rajive, Sharma Gunjan, Bakhshi Sameer, Pushpam Deepam, Ali M. Shadab, Ranjan Amar, Tanwar Pranay, Chauhan Shyam S., Singh Archna, Chopra Anita |
